Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 77,890 shares at $61.60 ($4.8M) on 2023-08-15, disclosed to the SEC on 2023-08-16.
Scheduled sale ($4.8M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.15 | 27,890 | $1.7M | 35.7% |
| 2 | $61.15 | 27,890 | $1.7M | 35.7% |
| 3 | $61.60 | 22,110 | $1.4M | 28.5% |
| Total | $61.28 avg | 77,890 | $4.8M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |